Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 7Recruiting 3Active not recruiting 3Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 10Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Neoplasm Metastasis 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1SCLC,Extensive Stage 1Rare Tumor 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Adenocarcinoma Metastatic 1Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Laryngeal Diseases 1Hemangiosarcoma 1Glioblastoma 1Endometrial Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Biliary Tract Neoplasms 1Advanced Solid Tumor 1

Interventions

Carboplatin 18Paclitaxel 17Bevacizumab 17olaparib 8Specimen Handling 7liposomal doxorubicin 6pembrolizumab 5Taxes 5Biopsy 5cemiplimab 4Magnetic Resonance Spectroscopy 4sarilumab 3niraparib 3mirvetuximab soravtansine 3Topotecan 3Standard of Care 3Letrozole 3Gemcitabine 3Cisplatin 3130-nm albumin-bound paclitaxel 3taxane 2talazoparib 2palbociclib 2abemaciclib 2Temozolomide 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Poly(ADP-ribose) Polymerase Inhibitors 2Immunoglobulin G 2Fulvestrant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Fallopian Tube Neoplasms × niraparib × Clear all
NCT06915025 2026-05-04

OVATION-3

Imunon

Phase 3 Recruiting
500 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05009082 2025-09-10

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

AGO Study Group

Phase 3 Recruiting
970 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
167 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡